Total Visits

Views
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis702

Total Visits Per Month

January 2016February 2016March 2016April 2016May 2016June 2016July 2016
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis3311116

File Visits

Views
cancers-03-01329.pdf652
license.txt63
sword-2012-02-16.original2

Top country views

Views
United States339
China85
Ireland69
Germany26
Russia16
Japan14
Netherlands14
United Kingdom11
France8
Belarus7

Top cities views

Views
Cleveland66
Mountain View56
Woodbridge42
Oranmore39
Sunnyvale35
Beijing30
Gaillimh19
Seattle11
Kiez8
Leipzig8